• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ST段抬高型心肌梗死伴或不伴糖尿病患者成功进行直接经皮冠状动脉介入治疗后心肌灌注的比较。

Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus.

作者信息

Timmer Jorik R, van der Horst Iwan C C, de Luca Giuseppe, Ottervanger Jan Paul, Hoorntje Jan C A, de Boer Menko-Jan, Suryapranata Harry, Dambrink Jan-Henk E, Gosselink Marcel, Zijlstra Felix, van 't Hof Arnoud W J

机构信息

Department of Cardiology, Isala Klinieken, Locatie Weezenlanden, Zwolle, The Netherlands.

出版信息

Am J Cardiol. 2005 Jun 1;95(11):1375-7. doi: 10.1016/j.amjcard.2005.01.088.

DOI:10.1016/j.amjcard.2005.01.088
PMID:15904649
Abstract

Patients with diabetes mellitus (DM) have an adverse prognosis after ST-segment elevation myocardial infarction (STEMI). Whether DM was associated with impaired myocardial reperfusion after successful primary percutaneous coronary intervention for STEMI was investigated. Myocardial reperfusion was assessed by ST-segment resolution and myocardial blush grade (MBG). A total of 386 patients were studied, of whom 64 (17%) had DM. These patients more frequently had reduced MBG (20% vs 10%, p = 0.02) and incomplete ST-segment resolution (55% vs 35%, p = 0.02) compared with patients without DM. After multivariate analysis, DM was still associated with impaired ST resolution (odds ratio 2.1, p = 0.03) and reduced MBG (odds ratio 2.2, p = 0.03).

摘要

糖尿病(DM)患者在ST段抬高型心肌梗死(STEMI)后预后不良。本研究旨在探讨DM是否与STEMI患者成功进行直接经皮冠状动脉介入治疗后心肌再灌注受损有关。通过ST段回落和心肌 blush 分级(MBG)评估心肌再灌注情况。共研究了386例患者,其中64例(17%)患有DM。与非DM患者相比,这些患者MBG降低(20%对10%,p = 0.02)和ST段不完全回落(55%对35%,p = 0.02)的情况更为常见。多因素分析后,DM仍与ST段回落受损(比值比2.1,p = 0.03)和MBG降低(比值比2.2,p = 0.03)有关。

相似文献

1
Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus.ST段抬高型心肌梗死伴或不伴糖尿病患者成功进行直接经皮冠状动脉介入治疗后心肌灌注的比较。
Am J Cardiol. 2005 Jun 1;95(11):1375-7. doi: 10.1016/j.amjcard.2005.01.088.
2
Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).ST段抬高型急性心肌梗死患者经皮冠状动脉介入治疗中合并与不合并糖尿病患者的心肌再灌注比较(来自EMERALD试验)
Am J Cardiol. 2007 Jul 15;100(2):206-10. doi: 10.1016/j.amjcard.2007.02.080. Epub 2007 Jun 4.
3
[Myocardial blush grade, ST-segment elevation resolution and prognosis in acute myocardial infarction patients with or without diabetes mellitus post primary percutaneous coronary intervention].[急性心肌梗死患者行直接经皮冠状动脉介入治疗后伴或不伴糖尿病的心肌 blush 分级、ST 段抬高消退情况及预后]
Zhonghua Xin Xue Guan Bing Za Zhi. 2007 May;35(5):439-42.
4
Effect of impaired myocardial reperfusion on left ventricular remodeling in patients with anterior wall acute myocardial infarction treated with primary coronary intervention.急性前壁心肌梗死患者接受直接冠状动脉介入治疗时心肌再灌注受损对左心室重构的影响
Am J Cardiol. 2006 Sep 15;98(6):725-8. doi: 10.1016/j.amjcard.2006.04.009. Epub 2006 Jul 26.
5
Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction.糖尿病对急性心肌梗死患者直接血管成形术后心肌灌注的影响。
J Am Coll Cardiol. 2005 Feb 15;45(4):508-14. doi: 10.1016/j.jacc.2004.10.054.
6
Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.直接冠状动脉血管成形术后心外膜血流与早期ST段恢复的预后价值比较。ANIN——心肌梗死登记处。
Kardiol Pol. 2007 Jan;65(1):1-10; discussion 11-2.
7
Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时的年龄、心肌灌注受损与死亡率
Eur Heart J. 2005 Apr;26(7):662-6. doi: 10.1093/eurheartj/ehi110. Epub 2005 Jan 28.
8
Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.心肌梗死溶栓治疗心肌灌注分级与ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后梗死灶结构的心血管磁共振测量指标的相关性
Am Heart J. 2009 Jul;158(1):84-91. doi: 10.1016/j.ahj.2009.04.012.
9
Prognostic implication of ST-segment resolution following primary percutaneous transluminal coronary angioplasty for ST-elevation acute myocardial infarction.ST段抬高型急性心肌梗死直接经皮冠状动脉腔内血管成形术后ST段回落的预后意义
Intern Med J. 2004 Sep-Oct;34(9-10):551-6. doi: 10.1111/j.1445-5994.2004.00649.x.
10
Grade 3 ischemia on the admission electrocardiogram predicts failure of ST resolution and of adequate flow restoration after primary percutaneous coronary intervention for acute myocardial infarction.入院心电图显示3级缺血可预测急性心肌梗死患者接受直接经皮冠状动脉介入治疗后ST段回落失败及血流恢复不足。
Am Heart J. 2007 Mar;153(3):410-7. doi: 10.1016/j.ahj.2006.12.004.

引用本文的文献

1
Triglycerides/High-Density Lipoprotein Ratio and Coronary Artery Disease: Results from a Large Single-Center Study.甘油三酯/高密度脂蛋白比值与冠状动脉疾病:一项大型单中心研究的结果
J Clin Med. 2025 Feb 19;14(4):1371. doi: 10.3390/jcm14041371.
2
Current and Future Roles of Glycoprotein IIb-IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction.糖蛋白IIb-IIIa抑制剂在ST段抬高型心肌梗死直接血管成形术中的当前及未来作用
Biomedicines. 2024 Sep 4;12(9):2023. doi: 10.3390/biomedicines12092023.
3
Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes.
靶向炎症的新机遇:心肌梗死和 2 型糖尿病。
Cardiovasc Res. 2024 Sep 21;120(11):1241-1252. doi: 10.1093/cvr/cvae142.
4
Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes.维生素D与心血管疾病:从生理学到病理生理学及预后
Biomedicines. 2024 Mar 30;12(4):768. doi: 10.3390/biomedicines12040768.
5
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.ESC 工作组关于“心血管疾病中的冠状动脉微血管功能障碍”的冠状动脉病理生理学和微循环立场文件
Cardiovasc Res. 2020 Mar 1;116(4):741-755. doi: 10.1093/cvr/cvaa003.
6
Effect of stress hyperglycaemia on monocyte chemoattractant protein-1 levels and the short-term prognosis of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.应激性高血糖对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者单核细胞趋化蛋白-1水平及短期预后的影响
Exp Ther Med. 2019 May;17(5):3823-3829. doi: 10.3892/etm.2019.7338. Epub 2019 Mar 4.
7
Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.糖尿病中心肌细胞膜和微区的改变:决定缺血耐受和心脏保护的因素。
Cardiovasc Diabetol. 2017 Dec 4;16(1):155. doi: 10.1186/s12933-017-0638-z.
8
Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy.糖尿病对接受双联抗血小板治疗患者未成熟血小板分数的影响及其与血小板反应性的关系。
J Thromb Thrombolysis. 2016 Aug;42(2):245-53. doi: 10.1007/s11239-016-1348-1.
9
Diabetes mellitus and glucose as predictors of mortality in primary coronary percutaneous intervention.糖尿病和血糖作为原发性冠状动脉介入治疗中死亡率的预测因素。
Arq Bras Cardiol. 2014 Oct;103(4):323-30. doi: 10.5935/abc.20140130. Epub 2014 Sep 12.
10
Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation.糖尿病对直接经皮冠状动脉介入治疗后长期预后的影响:DESERT 合作研究的见解。
Diabetes Care. 2013 Apr;36(4):1020-5. doi: 10.2337/dc12-1507. Epub 2012 Dec 28.